AAV‐Tau injection in the substantia nigra as a rapid and robust mouse model of tauopathies with Parkinsonian features
The early development of motor deficits and regional brain atrophy observed in AAV-Tau-injected mice makes this translational model a valuable and reliable tool for preclinical efficacy studies aimed at accelerating the development of disease-modifying therapeutic interventions for tauopathies with Parkinsonian features, such as Progressive Supranuclear Palsy (PSP) and Corticobasal Degeneration (CBD).
Authors
- Anastasia Noël (ORCID: https://orcid.org/0000-0003-4405-3828)
- Élodie Brison
- Barry J Bedell
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/alz70855_102244
- Primary Topic
- Parkinson's Disease Mechanisms and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00